The therapeutic contribution of proteomic approaches in cancers | L'apport thérapeutique des approches protéomiques dans les cancers Review uri icon

Overview

MeSH Major

  • Neoplasms
  • Proteomics

abstract

  • Up to now, there are no protein tumor markers with a specificity and sensitivity sufficient to have a utility in prognosis and early diagnosis of cancer. Recent advances in proteomics approaches have led to the identification of novel tumor markers of cancer that may have a utility in screening strategies and treatment. The purpose of the current review is to describe the major advances in cancer proteomics, especially those related to the study of serum biomarkers, immune-related responses (autoantibodies) and alterations in cellular proteins.

publication date

  • February 2011

Research

keywords

  • Review

Identity

Language

  • fre

Digital Object Identifier (DOI)

  • 10.1016/j.gyobfe.2010.12.005

PubMed ID

  • 21317010

Additional Document Info

start page

  • 87

end page

  • 93

volume

  • 39

number

  • 2